Dogwood Therapeutics Files Q1 2025 10-Q
Ticker: DWTX · Form: 10-Q · Filed: May 9, 2025 · CIK: 1818844
| Field | Detail |
|---|---|
| Company | Dogwood Therapeutics, INC. (DWTX) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: DWTX
TL;DR
Dogwood Therapeutics (DWTX) filed its Q1 2025 10-Q. Financials are in.
AI Summary
Dogwood Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Virios Therapeutics, Inc., reported financial data for its fiscal quarter. Key financial figures and stock information are detailed within the filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and position of Dogwood Therapeutics, Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Dogwood Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2213.8044 — Financial Metric (Reported for the quarter ending March 31, 2025)
- 284.2638 — Financial Metric (Reported for the quarter ending March 31, 2025)
Key Players & Entities
- Dogwood Therapeutics, Inc. (company) — Filer of the 10-Q
- Virios Therapeutics, Inc. (company) — Former name of Dogwood Therapeutics, Inc.
- 20250331 (date) — End of the reporting period
- 20250509 (date) — Filing date
- 2213.8044 (dollar_amount) — Financial figure for the period
- 284.2638 (dollar_amount) — Financial figure for the period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2025.
What was Dogwood Therapeutics, Inc. formerly known as?
Dogwood Therapeutics, Inc. was formerly known as Virios Therapeutics, Inc. and Virios Therapeutics, LLC.
When was the company's name changed from Virios Therapeutics, Inc.?
The name change from Virios Therapeutics, Inc. occurred on December 17, 2020.
What is the company's primary business classification?
The company is classified under Pharmaceutical Preparations [2834].
What is the filing date of this 10-Q?
This 10-Q was filed on May 9, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding Dogwood Therapeutics, Inc. (DWTX).